Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4214838
Max Phase: Preclinical
Molecular Formula: C32H41Cl2FN4O7
Molecular Weight: 683.61
Molecule Type: Small molecule
Associated Items:
ID: ALA4214838
Max Phase: Preclinical
Molecular Formula: C32H41Cl2FN4O7
Molecular Weight: 683.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCc1cc(Cl)c(CN2C[C@@H](F)C[C@H]2C(=O)N2CCN(C3CC3)c3ccccc32)cc1Cl)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Standard InChI: InChI=1S/C32H41Cl2FN4O7/c33-22-12-19(23(34)11-18(22)5-8-29(43)36-14-27(41)30(44)31(45)28(42)17-40)15-37-16-20(35)13-26(37)32(46)39-10-9-38(21-6-7-21)24-3-1-2-4-25(24)39/h1-4,11-12,20-21,26-28,30-31,40-42,44-45H,5-10,13-17H2,(H,36,43)/t20-,26-,27-,28+,30+,31+/m0/s1
Standard InChI Key: DPDGVKIIRCOGEZ-QZOOIAGPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 683.61 | Molecular Weight (Monoisotopic): 682.2336 | AlogP: 1.41 | #Rotatable Bonds: 13 |
Polar Surface Area: 157.04 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.64 | CX Basic pKa: 4.75 | CX LogP: 0.95 | CX LogD: 0.95 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.18 | Np Likeness Score: -0.42 |
1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG.. (2018) Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)., 61 (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308] |
Source(1):